Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Relevance of the type I interferon signature in multiple sclerosis towards a personalized medicine approach for interferon-beta therapy.
What went wrong? The flawed concept of cerebrospinal venous insufficiency.
Ion Channels in Neurological Disorders.
The Use of Fourth-generation Optical Coherence Tomography in Multiple Sclerosis: A Review.
Immune-Inflammatory and Oxidative and Nitrosative Stress Biomarkers of Depression Symptoms in Subjects with Multiple Sclerosis: Increased Peripheral Inflammation but Less Acute Neuroinflammation.
Multiple sclerosis and pregnancy: a single-centre prospective comparative study.
Detrusor sphincter dyssynergia: a review of physiology, diagnosis, and treatment strategies.
How does fingolimod (gilenya(®)) fit in the treatment algorithm for highly active relapsing-remitting multiple sclerosis?
The role of TPA I/D and PAI-1 4G/5G polymorphisms in multiple sclerosis.
Botulinum Toxin Injection Techniques for Management of Adult Spasticity.
Protective effects of 27- and 24-hydroxycholesterol against staurosporine-induced cell death in undifferentiated neuroblastoma SH-SY5Y cells.
Telehealth weight management intervention for adults with physical disabilities: a randomized controlled trial.
A mechanistic, stochastic model helps understand multiple sclerosis course and pathogenesis.
Myelin damage and repair in pathologic CNS: challenges and prospects.
The Olig family affects central nervous system development and disease.
Blood Plasma Levels of Microelements in Patients with History of Optic Neuritis.
[Therapeutic plasma exchange: applications in neurology].
Inhibition of Gli1 mobilizes endogenous neural stem cells for remyelination.
Risk stratification and mitigation in multiple sclerosis.
Can multiple sclerosis as a cognitive disorder influence patients' dreams?
The relationship between cognitive function and high-resolution diffusion tensor MRI of the cingulum bundle in multiple sclerosis.
Chatting with the neighbors: crosstalk between Rho-kinase (ROCK) and other signaling pathways for treatment of neurological disorders.
Opportunistic DNA Recombination with Epstein-Barr Virus at Sites of Control Region Rearrangements Mediating JC Virus Neurovirulence.
Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis.
Anti-MOG antibodies are under polygenic regulation with the most significant control coming from the C-type lectin-like gene locus.
Pages
« first
‹ previous
…
401
402
403
404
405
406
407
408
409
…
next ›
last »